STAND. COM. REP. NO. 1005
Honolulu, Hawaii
, 2005
RE: S.C.R. No. 29
S.D. 1
Honorable Robert Bunda
President of the Senate
Twenty-Third State Legislature
Regular Session of 2005
State of Hawaii
Sir:
Your Committee on Health, to which was referred S.C.R. No. 29 entitled:
"SENATE CONCURRENT RESOLUTION REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF REQUIRING HEALTH INSURERS TO OFFER COVERAGE FOR THE EARLY DETECTION OF PROSTATE CANCER IN ACCORDANCE WITH THE PROSTATE CANCER EARLY DETECTION GUIDELINES OF THE NATIONAL COMPREHENSIVE CANCER NETWORK,"
begs leave to report as follows:
The purpose of this measure is to request the Auditor to assess the social and financial effect of requiring health insurers to offer coverage for the early detection of prostate cancer in accordance with the prostate cancer early detection guidelines of the National Comprehensive Cancer Network.
The American Cancer Society submitted testimony in support of this measure. Kaiser Permanente submitted testimony in opposition.
Your Committee finds that prostate cancer is the most common form of cancer, other than skin cancer, among men in the United States. In Hawaii, approximately seven hundred cases of invasive prostate cancer are diagnosed each year and another one hundred men die from the disease annually. Before any legislative measure can mandate health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual group health insurance policies, the Auditor must prepare and submit a report assessing the social and financial effects of the proposed mandated coverage to the Legislature.
There is apparently a lack of agreement among several credible health care organizations and governmental agencies about prostate cancer screening guidelines. Your Committee notes that the importance of this measure is screening, early detection and treatment for prostate cancer, and not hard and fast recognition of any particular guideline.
Upon further consideration, your Committee has amended this measure by deleting the specific reference to the National Comprehensive Cancer Network and referring generally to guidelines of other health care organizations including, but not limited to, the National Comprehensive Cancer Network, the American Cancer Society, the Centers for Disease Control and the U.S. Preventive Services Task Force.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee concurs with the intent and purpose of S.C.R. No. 29, as amended herein, and recommends that it be referred to the Committee on Commerce, Consumer Protection, and Housing, in the form attached hereto as S.C.R. No. 29, S.D. 1.
Respectfully submitted on behalf of the members of the Committee on Health,
____________________________ ROSALYN H. BAKER, Chair |
||